Cardiovascular Diseases Clinical Trial
Official title:
Internet-based Vascular Risk Factor Management for Patients With Clinical Manifest Vascular Disease; a Randomized Controlled Trial
The objective of the study is to evaluate the efficacy and cost-effectiveness of an internet based vascular risk factor program on top of usual care compared to usual care alone for treatment of vascular risk factors in patients at high risk for new vascular events.
The objective of the study is to evaluate the efficacy and cost-effectiveness of an internet
based vascular risk factor program on top of usual care compared to usual care alone for
treatment of vascular risk factors in patients at high risk for new vascular events.
Study design: randomized non-blinded trial Study population: patients in the Rijnstate
Hospital Arnhem and the UMC Utrecht, The Netherlands with a recent diagnosis of cerebral,
cardiac or peripheral artery disease that entered the risk factor screening programs in
these hospitals revealing 2 or more treatable risk factors.
Intervention: After the screening program patients will be randomized to usual care alone or
to the internet program on top of usual care. Usual care for risk factor management will be
delivered by the medical specialist and/or the general practitioner. Patients randomized to
the internet based intervention program are first seen by the nurse practitioner on a
regular clinic visit. The internet dossier is than created and explained to the patient.
Subsequent contacts between nurse practitioner and patient about risk factor management is
mainly by the internet. The nurse practitioner works according to the national guidelines
for cardiovascular risk management ('CardioVascular Risico Management 2006') and is
supervised by an internist. The study period is 1 year. All patients in both groups ware
asked to return to the clinic for a follow up measurement of risk factors after 1 year.
Outcome measures: Primary outcome is the difference in Framingham heart risk score between
baseline and after 1 year. As secondary outcome the percentage of patients achieving
treatment goals for each risk factor and the average change in the absolute value of each
risk factors after 1 year will be used.
Sample size calculation/data analysis: 380 patients. Changes in risk factors (absolute
change and fraction of patients achieving treatment goal of each risk factor) at the start
and after 1 year and between the groups are tested with independent sample t-test and
Chi-square test.
Economic evaluation: The balance between costs and effects of the internet based vascular
risk factor management program will be compared to usual care. Using a previously developed
cardiovascular disease model incremental cost-utility analyses will be conducted with
remaining life expectancy as the relevant time horizon.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
| Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
| Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
| Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
| Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
| Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
| Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
| Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
| Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
| Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
| Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
| Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
| Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
| Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
| Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
| Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|